A cDNA clone containing the entire vesicular stomatitis virus nucleocapsid gene was assembled by fusing portions of two partial clones. When the cDNA clone was inserted into a new general-purpose eucaryotic expression vector and introduced into appropriate host cells, abundant N-protein synthesis ensued. The expressed protein was indistinguishable from authentic N protein produced during vesicular stomatitis virus infections. The recombinant N protein was recognized by a polyclonal antibody and two different monoclonal antibodies and could not be resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis from authentic N. Our results suggest that the recombinant N protein produced in transfected cells rapidly aggregates into high-molecular-weight complexes in the absence of vesicular stomatitis virus genomic RNA.
A cDNA clone containing the entire vesicular stomatitis virus nucleocapsid gene was assembled by fusing portions of two partial clones. When the cDNA clone was inserted into a new general-purpose eucaryotic expression vector and introduced into appropriate host cells, abundant N-protein synthesis ensued. The expressed protein was indistinguishable from authentic N protein produced during vesicular stomatitis virus infections. The recombinant N protein was recognized by a polyclonal antibody and two different monoclonal antibodies and could not be resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis from authentic N. Our results suggest that the recombinant N protein produced in transfected cells rapidly aggregates into high-molecular-weight complexes in the absence of vesicular stomatitis virus genomic RNA.
Recent reports suggest that the nucleocapsid protein N plays a central role in regulating the replication of vesicular stomatitis virus (VSV) (1, 18 ; B. Blumberg, C. Giorgi, and D. Kolakofsky, Cell, in press). In the infected cell, fulllength genomic RNAs, whether negative or positive strand, are only found associated with this protein in the form of a very stable nucleocapsid structure. Viral mRNAs, which, in aggregate, contain all but 117 nucleotides of the sequences present in the genome-length positive-strand nucleocapsids, are virtually free of association with the N protein. Several reports have dealt with the speculation that RNA synthesis, once initiated, can proceed to yield either a genomelength positive strand or the five separate monocistronic mRNAs, depending upon the intracellular availability of the N protein (1, 17, 18) . The common feature of these models is the speculation that during N-protein sufficiency, nascent RNA transcripts are rapidly encapsidated, a process that releases the polymerase from a sitespecific attenuation and allows it to synthesize a genome-length RNA. In N-protein deficiency, as in in vitro transcriptions, the nascent transcripts are released; new transcripts initiated at specific sites along the templates are elongated to form the monocistronic mRNAs. Once formed, these mRNAs remain unencapsidated even during N-protein sufficiency because they do not contain the nucleation site-a sequence which is thought to be found only at the 5' termini of the positive or negative genomic RNAs. Thus, the N protein is thought to control the balance between transcriptive and replicative RNA synthesis in the infected cell.
Direct tests of this model have not been possible because of the inability to effectively divorce genomic RNA synthesis from encapsidation, alter the putative nucleation site at will, or vary the intracellular availability of N protein.
Recombinant DNA techniques and the use of chimeric cells which constitutively produce N protein may offer the degree of control over the replicative process that is needed.
In the present communication, we report the assembly of a complete DNA gene encoding the VSV N protein. We have positioned this gene in a simian virus 40 (SV40) cloning vector so that it is transcribed intracellularly as part of the major late SV40 mRNA and translated into a protein indistinguishable from its natural counterpart produced during VSV infections.
MATERIALS AND METHODS Virus cell lines and culture conditions. The Indiana strain of VSV (Mudd-Summers strain) used throughout this work was cultured on monolayers of BHK cells and purified as described previously (19) . Esche Double-stranded DNA was synthesized under the same general reaction condition, but without primer or RNA. Double-stranded cDNA was trimmed with S1 nuclease and tailed with oligodeoxycytidylic acid as previously described (9, 25) . The oligodeoxycytidylic acid-tailed cDNAs were hybridized with E. coli plasmid pBR322 which had been linearized by cleavage at the PstI site and tailed with oligodeoxyguanidylic acid, and the mixture was used to transform E. coli HB101 as described below. Ampicillin-sensitive colonies were screened by hybridization (13) with 32P-labeled leader RNA (5, 6 Cohen (24) . Labeled DNAs were cut with a second restriction endonuclease, and the uniquely labeled fragments were separated by polyacrylamide gel electrophoresis as previously described (21) . Labeled fragments recovered from the gel were sequenced by the chemical sequencing methods of Maxam (subclass IgGl), partially purified by ion-exchange chromatography from mouse ascites fluid, was adsorbed to the wells of polyvinyl chloride microtiter plates in phosphate-buffered saline (pH 7.4). Nonadsorbed antibody was washed away, the plates were treated with a solution of ovalbumin (3% in phosphatebuffered saline) for 2 h, and COS cell extracts were added for 4 h (50 p.1 per well). The wells were then washed, incubated for 2 h with a rabbit anti-VSV serum (dilution, 1:500), washed, incubated for 2 h with GENE CODING FOR VSV NUCLEOCAPSID PROTEIN 775 0.1% SDS) on 25-cm-long slab gels. The radiolabeled proteins were visualized by fluorography.
RESULTS
Cloning the 3' terminus of VSV RNA. To produce cDNA clones in which the terminal sequences were completely represented we employed a synthetic octadeoxynucleotide that is the complement of the extreme 3' terminus of the VSV RNA. Using this oligo deoxynucleotide as a primer, we were able to stimulate reverse transcription of the VSV RNA about 1.5-fold above that found in the absence of exogenous primer. Double-stranded cDNA transcripts were prepared, inserted into pBR322, and cloned as indicated above. Clones were screened by colony hybridization by using 32P-labeled leader RNAs, a family of short transcripts from the extreme 3' terminus of the VSV genome (5, 6) . Approximately 7% of the VSV containing clones contained portions of the leader sequence that could be detected by colony hybridization. Most of these leader RNA-positive clones were incomplete and lacked one or more nucleotides of the complete 3' terminal VSV sequence. One complete clone, pJS77, was selected for further investigation.
The VSV sequences of pJS77 (approximately 360 base pairs) were excised from the plasmid and terminally labeled with cordycepin [32P]triphosphate. The VSV insert was cut with BglII, which was a unique site at position 210; the labeled fragment containing the 3' terminal sequence of VSV was purified by gel electrophoresis, and its sequence was determined by chemical sequencing (21) . The results confirmed the presence of the complete VSV 3'-terminal sequence in the cloned fragment preceded by the oligodeoxycytidylic acid tail introduced by tailing with terminal transferase. We have not sequenced the entire clone since the sequence of that portion of the VSV genome has been reported (11) . We have confirmed the identity of the balance of the insert by restriction endonuclease mapping. When digested with BamHI, MboII, DdeI, Hinfl, HincII, AccI, BglII, and AluI endonucleases, the cloned fragment yields the number and size fragments predicted from the sequence published by Gallione et al. (11) .
Assembly of cDNA coding for VSV nucleocapsid protein. The clone of the 3' terminus of VSV, pJS77, described above, overlaps the portion of the N gene cloned by Gallione et al. (11) . The overlapping region of the two clones contained a unique BglII site at which they could be conveniently joined to form a cDNA spanning the entire N gene. Because the N gene contains an internal PstI site, we changed the terminal sequences of each clone to XhoI sites so that the assembled N gene could be easily retrieved from the plasmid and manipulated as a single fragment. The strategy and schematic diagram of the assembly process are illustrated in Fig. 1 [3] to identify positions on the SV40 genome.) To insert a unique cloning site into this vector, pSV53 was digested with BamHI, and the termini were filled in with DNA polymerase 1 and blunt-end ligated to XhoI linkers. This SV40 fragment was then recloned into the XhoI site of pMK2004, and recombinants were identified by colony hybridization with nick-translated SV40 DNA. One such recombinant plasmid (pJC32) was passed through the dam strain GM33 to obtain an unmethylated version which could be cut with BclI. The SV40 fragment was isolated by digestion with XhoI and FnuDII (to fragment the plasmid) and purified by sucrose gradient centrifugation. After recircularization with T4 DNA ligase, the SV40 fragment was linearized by digestion with BclI and cloned into the BamHI site of the poison-negative plasmid pML2 (20) (Fig. 3) . This granularity was consistently found and was not dependent upon the particular combination of immunoreagents: it was observed when either monoclonal or polyclonal anti-nucleocapsid ____~antibodies were employed. Granular fluorescence also was observed in VSV-infected cells when they were probed with anti-nucleocapsid antiserum, suggesting that both the nucleocapsids and the N protein tend to concentrate in electrophoretic areas of the cytoplasm. To further explore these s f . Ctdoplith thc observations, we prepared extracts of cells exontaining the N pressing the cloned N gene and fractionated iionine for 24 h them by velocity sedimentation in sucrose gradi--ction. Samples ents. The profile of the velocity separation ( (37,000 rpm, 4°C, 100 min) or on (B) linear 20 to 40% (wt/wt) CSCI gradients (33,000 rpm, 4°C, 24 h). The gradients were fractionated, and the N protein content of each fraction was determined by a solid-phase radioimmunoassay as described in the text. The density of the relevant CsCl gradient fractions was determined by weighing 100-,u samples and is shown in the insert of panel B. The positions to which 140S and 80S material sedimented was determined with nucleocapsids from VSV or the small defective particle DI 011.
Had the association of the N protein been disrupted by the high concentration of CsCl, the monomeric N protein generated would not sediment fast enough to form a band during the centrifugation. Indeed, virtually all of the protein detected by the Lowry assay is located at the top of the CsCl gradients in fractions 15 to 23.
DISCUSSION
In this communication, we report the successful cDNA cloning of the VSV 3' terminus. The clone obtained, pJS77, overlaps a cDNA clone previously described (11) . Using the two overlapping cDNA clones, we have assembled a complete VSV nucleocapsid gene. The assembled nucleocapsid gene is derived from two different strains of VSV (Indiana), the MuddSummers strain and the San Juan strain. Despite the fact that sequence differences have been noted between these two strains, the sequence of the leader-proximal portions of the N gene derived from the Mudd-Summers strain is the same as that reported for the San Juan strain (11 (10, 16 
